Apyx Medical Corp. (APYX) Tops Q4 EPS by 7c, Revenues Beat; Offers FY21 Revenues Guidance Below Consensus

Go back to Apyx Medical Corp. (APYX) Tops Q4 EPS by 7c, Revenues Beat; Offers FY21 Revenues Guidance Below Consensus
(NASDAQ: APYX) Delayed: 2.37 -0.04 (1.66%)
Previous Close $2.41    52 Week High $ 
Open $2.39    52 Week Low $ 
Day High $2.40    P/E N/A 
Day Low $2.25    EPS $ 
Volume 146,167